Skip to main content

Table 2 Results of econometric models of healthcare costs associated with exudative AMD

From: Incremental economic burden associated with exudative age-related macular degeneration: a population-based study

Variables

Ordinary least square

Generalized linear model

Beta (95% CI)

P-value

Beta (95% CI)

P-value

AMD

2.13 (2.08 to 2.17)

< 0.001

1.40 (1.34 to 1.46)

< 0.001

Age group

−0.02 (− 0.03 to − 0.00)

0.016

0.06 (0.04 to 0.07)

< 0.001

Sex

0.13 (0.09 to 0.18)

< 0.001

0.05 (−0.01 to 0.11)

0.102

Insurance

0.01 (−0.04 to 0.05)

0.769

0.05 (−0.01 to 0.10)

0.097

Residence

−0.00 (− 0.03 to 0.02)

0.908

0.00 (− 0.03 to 0.04)

0.805

Disability

0.13 (0.06 to 0.20)

< 0.001

0.25 (0.17 to 0.34)

< 0.001

Charlson comorbidity index

0.22 (0.18 to 0.27)

< 0.001

0.21 (0.15 to 0.26)

< 0.001

Length of hospitalization

0.01 (0.01 to 0.01)

< 0.001

0.01 (0.01 to 0.01)

< 0.001

Number of outpatient visits

0.01 (0.01 to 0.02)

< 0.001

0.01 (0.01 to 0.01)

< 0.001

Number of ED visits

0.02 (−0.03 to 0.08)

0.426

0.05 (− 0.02 to 0.12)

0.179

  1. AMD age-related macular degeneration, CI confidence interval, ED emergency department